Document Detail


Iron overload in MDS-pathophysiology, diagnosis, and complications.
MedLine Citation:
PMID:  20938663     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Many patients with myelodysplastic syndromes (MDS) become dependent on blood transfusions and develop transfusional iron overload, which is exacerbated by increased absorption of dietary iron in response to ineffective erythropoiesis. However, it is uncertain whether there is an association among iron accumulation, clinical complications, and decreased likelihood of survival in MDS patients. Here, we discuss our current understanding of the effects of transfusion dependency and iron overload in MDS, indicate our knowledge gaps, and suggest that particular emphasis should be placed on further characterizing the role of redox-active forms of labile iron, which may be as important as the total iron burden.
Authors:
Norbert Gattermann; Eliezer A Rachmilewitz
Related Documents :
7803273 - Red cell membrane protein abnormalities in hereditary spherocytosis in brazil.
10028983 - Thiamine deficiency and malaria in adults from southeast asia.
2305763 - Prospective peritoneal scintigraphy in patients beginning continuous ambulatory periton...
Publication Detail:
Type:  Journal Article; Review     Date:  2010-10-12
Journal Detail:
Title:  Annals of hematology     Volume:  90     ISSN:  1432-0584     ISO Abbreviation:  Ann. Hematol.     Publication Date:  2011 Jan 
Date Detail:
Created Date:  2011-01-03     Completed Date:  2011-01-28     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9107334     Medline TA:  Ann Hematol     Country:  Germany    
Other Details:
Languages:  eng     Pagination:  1-10     Citation Subset:  IM    
Affiliation:
Department of Hematology, Oncology and Clinical Immunology, Heinrich-Heine-University, Mooren Str. 5, 40225, Düsseldorf, Germany. gattermann@med.uni-duesseldorf.de
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Blood Transfusion
Cell Transformation, Neoplastic / metabolism,  pathology
Humans
Iron Chelating Agents / therapeutic use
Iron Overload / complications*,  diagnosis*,  epidemiology,  etiology*
Life Expectancy
Models, Biological
Myelodysplastic Syndromes / complications*,  diagnosis,  epidemiology,  therapy
Oxidative Stress / physiology
Chemical
Reg. No./Substance:
0/Iron Chelating Agents

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Indoleamine 2,3-dioxygenase in tumor tissue indicates prognosis in patients with diffuse large B-cel...
Next Document:  Fulvestrant 250 mg versus anastrozole for Chinese patients with advanced breast cancer: results of a...